Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Urogenital Neoplasms × ixabepilone × Clear all

Sponsor

Conditions

Breast Neoplasms 32 Neoplasms 5 Prostatic Neoplasms 3 Neoplasm Metastasis 3 Carcinoma, Ovarian Epithelial 3 Pancreatic Neoplasms 2 Lung Neoplasms 2 Kidney Neoplasms 2 Fallopian Tube Neoplasms 2 Endometrial Neoplasms 2 Carcinoma, Renal Cell 2 Carcinoma, Non-Small-Cell Lung 2 Breast Neoplasms, Male 2 Uterine Cervical Neoplasms 1 Stomach Neoplasms 1 Solid Malignancies 1 Sarcoma 1 Recurrent Uterine Corpus Sarcoma 1 Recurrence 1 Pain 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Mantle-Cell 1 Lymphoma, Large-Cell, Anaplastic 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, Follicular 1 Liver Neoplasms 1 Head and Neck Neoplasms 1 Gliosarcoma 1 Glioblastoma 1 Endometrial Adenocarcinoma 1

Interventions

Sunitinib 2 Paclitaxel 2 valrubicin 1 temsirolimus 1 sipuleucel-T 1 luprolide acetate gel depot 1 ferumoxtran-10 1 abiraterone 1 abemaciclib 1 Suspensions 1 Surveys and Questionnaires 1 Standard of Care 1 Radiotherapy 1 Prednisone 1 Prednisolone 1 Powders 1 Pemetrexed 1 Neoadjuvant Therapy 1 Magnetic Resonance Spectroscopy 1 Leuprolide 1 Educational Status 1 Docetaxel 1 Bevacizumab 1 Administration, Intravesical 1 2-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡